Literature DB >> 32712673

Successful treatment of refractory mandibular lesions in SAPHO syndrome with secukinumab.

Boyuan Sun1, Yihan Cao2, Lun Wang1, Mu Wang3, Chen Li4.   

Abstract

Mesh：

Substances：

Year:  2021        PMID： 32712673     DOI： 10.1093/rheumatology/keaa352

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  3 in total

Review 1.  New Insights in the Treatment of SAPHO Syndrome and Medication Recommendations.

Authors:  Wei Cheng; Fen Li; Jing Tian; Xi Xie; Jin-Wei Chen; Xiao-Fei Peng; Qi Tang; Yan Ge
Journal:  J Inflamm Res       Date:  2022-04-13

Review 2.  Exceptional response of skin symptoms to secukinumab treatment in a patient with SAPHO syndrome: Case report and literature review.

Authors:  Qiang Ji; Qing Wang; Wenping Pan; Yanfeng Hou; Xiuhua Wang; Lin Bian; Zhankui Wang
Journal:  Medicine (Baltimore)       Date:  2022-08-19       Impact factor: 1.817

Review 3.  New insights on multigenic autoinflammatory diseases.

Authors:  Petros Efthimiou; Olga Petryna; Priscila Nakasato; Apostolos Kontzias
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-09-03       Impact factor: 3.625
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.